[The neuroprotective role of EAAC1 in hippocampal injury following ischemia-reperfusion]

Nihon Yakurigaku Zasshi. 2021;156(1):21-25. doi: 10.1254/fpj.20069.
[Article in Japanese]

Abstract

Ischemic stroke is one of the most prevalent brain disorders and the major cause of long-term disability. In particularly, hippocampal injury after ischemia-reperfusion is a serious problem as it contributes to vascular dementia. Many researches have revealed that ischemia-reperfusion causes increase in reactive oxygen species production and disruption of neuronal Zn2+ homeostasis in the hippocampus, which induces hippocampal neuron death. Glutathione (GSH) is present in all mammalian cells and plays a crucial role in neuronal cell defense against oxidative stress. On the other hand, thiol group of GSH chemically chelates Zn2+ and functions as a regulator of neuronal Zn2+ homeostasis. These evidences suggest that neuronal GSH levels could be an important factor affecting neuronal surviving. The synthesis of GSH is largely influenced by intracellular cysteine availability. In neurons, excitatory amino acid carrier type 1 (EAAC1) acts as a cysteine transporter and provides cysteine substrate for GSH synthesis. Recently, several animal studies have revealed that promotion of neuronal GSH synthesis through EAAC1 reduces ischemia-induced hippocampal neuron death. This review aims to describe neuroprotective role of GSH against hippocampal injury following ischemia-reperfusion, focusing on EAAC1.

Publication types

  • Review

MeSH terms

  • Animals
  • Excitatory Amino Acid Transporter 3 / metabolism
  • Glutathione / metabolism
  • Glutathione / pharmacology
  • Hippocampus / metabolism
  • Ischemia
  • Neuroprotective Agents* / pharmacology
  • Oxidative Stress
  • Reperfusion
  • Reperfusion Injury*

Substances

  • Excitatory Amino Acid Transporter 3
  • Neuroprotective Agents
  • Glutathione